Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Table 1

Patients characteristics (𝑛=37).

Characteristics	No.
Sex
Male	23
Female	14
Age (yr)
Median	48
Range	27–72
ECOG
0-1	37
2	0
Extent of disease
Locally advanced	6
Metastasis	31
Pathology
Moderate	2
Poor	25
Other	10
Organs involved
Liver	12
Lung	2
Bone	3
Pelvic cavity	11
Virchow’s LN	3
Previous treatment
Exploratory laparotomy	8
Gastrectomy	7
Chemotherapy	0